Seo,Year,Cancer Type,Cancer Type 2,Cell Line,Coumarin Type,Dose Unit,Time,Time Unit,Coumarin Dose,Viability,SD Viability,Viability Control,SD Control
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,48,hours,5,93.33,8.23,95.68,3.13
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,48,hours,10,94.5,4.7,95.68,3.13
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,48,hours,20,92.15,6.66,95.68,3.13
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,48,hours,40,85.88,4.7,95.68,3.13
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,48,hours,80,65.88,6.27,95.68,3.13
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,72,hours,5,93.72,3.92,88.23,8.62
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,72,hours,10,85.88,7.84,88.23,8.62
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,72,hours,20,83.13,7.05,88.23,8.62
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,72,hours,40,76.86,10.19,88.23,8.62
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,72,hours,80,64.31,8.23,88.23,8.62
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,96,hours,5,92.94,7.84,81.56,8.23
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,96,hours,10,85.49,10.19,81.56,8.23
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,96,hours,20,81.56,3.13,81.56,8.23
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,96,hours,40,78.43,6.27,81.56,8.23
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,96,hours,80,49.41,1.96,81.56,8.23
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,120,hours,5,86.66,3.92,80.78,6.66
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,120,hours,10,81.17,8.62,80.78,6.66
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,120,hours,20,77.64,3.13,80.78,6.66
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,120,hours,40,73.72,5.88,80.78,6.66
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,120,hours,80,42.35,4.31,80.78,6.66
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,144,hours,5,79.6,4.7,77.25,6.66
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,144,hours,10,76.47,8.23,77.25,6.66
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,144,hours,20,73.72,3.13,77.25,6.66
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,144,hours,40,70.58,5.09,77.25,6.66
Abolhassani et al.,2023,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,144,hours,80,34.9,5.88,77.25,6.66
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,24,hours,16.7,99.25,4.32,99.38,3.11
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,24,hours,67,99.04,3.7,99.38,3.11
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,24,hours,134,97.71,3.09,99.38,3.11
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,48,hours,33.5,96.98,3.09,103.43,2.47
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,48,hours,67,84.53,3.7,103.43,2.47
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,48,hours,134,76.37,4.34,103.43,2.47
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,72,hours,67,87.02,4.32,110.65,8
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,72,hours,134,75.27,8.02,110.65,8
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,96,hours,16.7,80.24,7.95,82.62,6.41
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,96,hours,33.5,78.18,6.43,82.62,6.41
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,96,hours,67,62.05,4.28,82.62,6.41
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,96,hours,134,45.63,6.42,82.62,6.41
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,120,hours,16.7,91.8,3.67,91.46,3.06
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,120,hours,33.5,82.35,1.83,91.46,3.06
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,120,hours,67,60.04,9.48,91.46,3.06
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,120,hours,134,47.54,6.12,91.46,3.06
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,144,hours,16.7,88.86,1.83,88.2,3.67
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,144,hours,33.5,78.25,6.41,88.2,3.67
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,144,hours,67,56.34,7.95,88.2,3.67
Bagheri et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,144,hours,134,40.24,1.83,88.2,3.67
Charmforoshan et al.,2019,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,103.8,75,4.79,100,1
Charmforoshan et al.,2019,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,207.7,49.24,2.52,100,1
Charmforoshan et al.,2019,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,415.5,30.8,1,100,1
Charmforoshan et al.,2019,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,838,16.16,2.77,100,1
Epifano et al.,2013,Colon,Colon Carcinoma,HCT-116,Auraptene,μM,72,hours,2.5,86.41,9.43,100,9.05
Epifano et al.,2013,Colon,Colon Carcinoma,HCT-116,Auraptene,μM,72,hours,5,84.9,19.62,100,9.05
Epifano et al.,2013,Colon,Colon Carcinoma,HCT-116,Auraptene,μM,72,hours,10,70.18,19.63,100,9.05
Epifano et al.,2013,Colon,Colon Carcinoma,HCT-116,Auraptene,μM,72,hours,20,56.6,3.77,100,9.05
Epifano et al.,2013,Colon,Colon Carcinoma,HCT-116,Auraptene,μM,72,hours,40,45.66,17.35,100,9.05
Epifano et al.,2013,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,72,hours,2.5,90.94,4.53,99.62,12.45
Epifano et al.,2013,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,72,hours,5,86.41,4.53,99.62,12.45
Epifano et al.,2013,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,72,hours,10,75.09,7.55,99.62,12.45
Epifano et al.,2013,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,72,hours,20,55.09,16.6,99.62,12.45
Epifano et al.,2013,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,72,hours,40,28.3,2.26,99.62,12.45
Epifano et al.,2023,Glioma,Glioma,SHSY-5Y,Auraptene,μM,24,hours,12.25,81.44,6.09,100,1
Epifano et al.,2023,Glioma,Glioma,SHSY-5Y,Auraptene,μM,24,hours,25,75.34,5.54,100,1
Epifano et al.,2023,Glioma,Glioma,SHSY-5Y,Auraptene,μM,24,hours,50,62.04,1,100,1
Gkionis et al.,2021,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,1,99.11,7.12,100,1
Gkionis et al.,2021,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,10,89.91,6.23,100,1
Gkionis et al.,2021,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,50,70.91,4.75,100,1
Gkionis et al.,2021,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,100,26.11,6.82,100,1
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,48,hours,10,99.7,1.83,99.9,1
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,48,hours,20,100,1,99.9,1
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,72,hours,10,97.8,1.74,99.4,1.51
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,72,hours,20,95.7,4.3,99.4,1.51
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,72,hours,40,79.2,10.7,99.4,1.51
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,96,hours,10,81.2,15.58,98.9,2.01
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,96,hours,20,87.3,3.52,98.9,2.01
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Auraptene,μM,96,hours,40,76,11.61,98.9,2.01
Hosseini et al.,2025,Bone,Osteosarcoma,MG-63,Auraptene,μM,24,hours,25,99.8,0.83,96,5.54
Hosseini et al.,2025,Bone,Osteosarcoma,MG-63,Auraptene,μM,24,hours,50,95.7,7.48,96,5.54
Hosseini et al.,2025,Bone,Osteosarcoma,MG-63,Auraptene,μM,24,hours,100,91.3,1.11,96,5.54
Hosseini et al.,2025,Bone,Osteosarcoma,MG-63,Auraptene,μM,48,hours,25,99.7,0.83,95.6,0.83
Hosseini et al.,2025,Bone,Osteosarcoma,MG-63,Auraptene,μM,48,hours,50,93.5,5.82,95.6,0.83
Hosseini et al.,2025,Bone,Osteosarcoma,MG-63,Auraptene,μM,48,hours,100,90.2,7.21,95.6,0.83
Jalilzade et al.,2020,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,24,hours,50,84.99,5.34,99.9,1.97
Jalilzade et al.,2020,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,24,hours,100,75.42,2.53,99.9,1.97
Jalilzade et al.,2020,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,48,hours,12.5,80.44,1.59,99.82,2.39
Jalilzade et al.,2020,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,48,hours,25,61.85,1.86,99.82,2.39
Jalilzade et al.,2020,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,48,hours,50,50.7,1.86,99.82,2.39
Jalilzade et al.,2020,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,48,hours,100,38.76,1.59,99.82,2.39
Jalilzade et al.,2020,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,72,hours,12.5,76.01,1.75,100,2.04
Jalilzade et al.,2020,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,72,hours,25,59.12,2.91,100,2.04
Jalilzade et al.,2020,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,72,hours,50,46.89,3.2,100,2.04
Jalilzade et al.,2020,Colon,Colon Adenocarcinoma,HT-29,Auraptene,μM,72,hours,100,42.52,5.53,100,2.04
Jamialahmadi et al.,2018,Ovarian,Ovarian Adenocarcinoma,A2780,Auraptene,μM,24,hours,3.13,88.38,6.36,100,1
Jamialahmadi et al.,2018,Ovarian,Ovarian Adenocarcinoma,A2780,Auraptene,μM,24,hours,6.25,82.32,2.38,100,1
Jamialahmadi et al.,2018,Ovarian,Ovarian Adenocarcinoma,A2780,Auraptene,μM,24,hours,12.5,71.21,5.57,100,1
Jamialahmadi et al.,2018,Ovarian,Ovarian Adenocarcinoma,A2780,Auraptene,μM,24,hours,25,55.34,6.1,100,1
Jamialahmadi et al.,2018,Ovarian,Ovarian Adenocarcinoma,A2780,Auraptene,μM,24,hours,50,41.59,3.44,100,1
Jamialahmadi et al.,2018,Ovarian,Ovarian Adenocarcinoma,A2780,Auraptene,μM,24,hours,100,22.53,1,100,1
Jamialahmadi et al.,2018,Cervical,Cervical Adenocarcinoma,HeLa,Auraptene,μM,24,hours,3.13,88.35,11.65,100,1
Jamialahmadi et al.,2018,Cervical,Cervical Adenocarcinoma,HeLa,Auraptene,μM,24,hours,6.25,85.44,7.41,100,1
Jamialahmadi et al.,2018,Cervical,Cervical Adenocarcinoma,HeLa,Auraptene,μM,24,hours,12.5,72.25,19.84,100,1
Jamialahmadi et al.,2018,Cervical,Cervical Adenocarcinoma,HeLa,Auraptene,μM,24,hours,25,69.04,5.03,100,1
Jamialahmadi et al.,2018,Cervical,Cervical Adenocarcinoma,HeLa,Auraptene,μM,24,hours,50,64.28,9.26,100,1
Jamialahmadi et al.,2018,Cervical,Cervical Adenocarcinoma,HeLa,Auraptene,μM,24,hours,100,18.78,3.45,100,1
Jun et al.,2007,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Auraptene,μM,20,hours,16.8,98.6,1.95,99.44,2.5
Jun et al.,2007,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Auraptene,μM,20,hours,33.6,87.89,2.87,99.44,2.5
Jun et al.,2007,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Auraptene,μM,20,hours,50.4,61.28,3.06,99.44,2.5
Jun et al.,2007,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Auraptene,μM,20,hours,67.2,36.62,1.91,99.44,2.5
Jun et al.,2007,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Auraptene,μM,20,hours,100.8,15.92,1.27,99.44,2.5
Jun et al.,2007,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Auraptene,μM,20,hours,134.4,15.6,1.27,99.44,2.5
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,24,hours,5,95.75,4.11,100,1
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,24,hours,10,96.98,6.99,100,1
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,24,hours,15,76.84,4.11,100,1
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,24,hours,20,74.79,5.34,100,1
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,24,hours,25,65.34,5.75,100,1
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,24,hours,30,56.71,5.34,100,1
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,24,hours,40,51.78,4.52,100,1
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,24,hours,50,51.36,5.35,100,1
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,1,89.04,6.18,100,9.01
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,2,98.87,10.68,100,9.01
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,10,68.25,8.99,100,9.01
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,15,25.28,5.33,100,9.01
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,20,18.82,3.93,100,9.01
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,25,15.73,1.96,100,9.01
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,30,15.16,2.53,100,9.01
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,40,16.57,1.96,100,9.01
Krishnan et al.,2009,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,50,17.97,2.53,100,9.01
Lee et al.,2017,Prostate,Prostate Carcinoma,DU145,Auraptene,μM,24,hours,15,72.04,2.31,100,1
Lee et al.,2017,Prostate,Prostate Carcinoma,DU145,Auraptene,μM,24,hours,30,60.21,3.58,100,1
Lee et al.,2017,Prostate,Prostate Carcinoma,DU145,Auraptene,μM,24,hours,60,56.45,2.33,100,1
Lee et al.,2017,Prostate,Prostate Carcinoma,DU145,Auraptene,μM,24,hours,90,41.03,2.28,100,1
Lee et al.,2017,Prostate,Prostate Carcinoma,DU145,Auraptene,μM,24,hours,120,33.15,5.02,100,1
Lee et al.,2017,Prostate,Prostate Carcinoma,LNCaP,Auraptene,μM,24,hours,15,87.81,3.59,100,2.24
Lee et al.,2017,Prostate,Prostate Carcinoma,LNCaP,Auraptene,μM,24,hours,30,79.3,1.57,100,2.24
Lee et al.,2017,Prostate,Prostate Carcinoma,LNCaP,Auraptene,μM,24,hours,60,70.34,1.56,100,2.24
Lee et al.,2017,Prostate,Prostate Carcinoma,LNCaP,Auraptene,μM,24,hours,90,62.72,3.36,100,2.24
Lee et al.,2017,Prostate,Prostate Carcinoma,LNCaP,Auraptene,μM,24,hours,120,57.34,2.24,100,2.24
Lee et al.,2017,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,24,hours,15,99.68,2.02,100,3.36
Lee et al.,2017,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,24,hours,30,80.42,7.84,100,3.36
Lee et al.,2017,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,24,hours,60,63.39,3.36,100,3.36
Lee et al.,2017,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,24,hours,90,60.48,2.91,100,3.36
Lee et al.,2017,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,24,hours,120,43.68,2.46,100,3.36
Li et al.,2024,Liver,Liver Carcinoma,HCCLM3,Auraptene,μM,16,hours,50,85.97,1,95.28,1
Li et al.,2024,Liver,Liver Carcinoma,HCCLM3,Auraptene,μM,16,hours,100,78.06,1,95.28,1
Li et al.,2024,Liver,Liver Carcinoma,HCCLM3,Auraptene,μM,16,hours,150,65.31,1.15,95.28,1
Li et al.,2024,Liver,Liver Carcinoma,HCCLM3,Auraptene,μM,16,hours,200,60.84,1.4,95.28,1
Li et al.,2024,Liver,Liver Carcinoma,HLE ,Auraptene,μM,16,hours,50,82.02,1,95.41,1
Li et al.,2024,Liver,Liver Carcinoma,HLE ,Auraptene,μM,16,hours,100,71.56,1,95.41,1
Li et al.,2024,Liver,Liver Carcinoma,HLE ,Auraptene,μM,16,hours,150,63.39,1.02,95.41,1
Li et al.,2024,Liver,Liver Carcinoma,HLE ,Auraptene,μM,16,hours,200,57.65,1.66,95.41,1
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,AGS,Auraptene,μM,48,hours,12.5,92.84,13.58,100,2.91
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,AGS,Auraptene,μM,48,hours,25,80.73,9.91,100,2.91
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,AGS,Auraptene,μM,48,hours,50,48.44,6.23,100,2.91
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,AGS,Auraptene,μM,48,hours,100,42.2,4.03,100,2.91
Moon et al.,2015,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,48,hours,50,67.88,14.68,100,6.6
Moon et al.,2015,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,48,hours,100,35.59,3.67,100,6.6
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,SNU-1,Auraptene,μM,48,hours,12.5,66.42,15.78,100,3.67
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,SNU-1,Auraptene,μM,48,hours,25,44.77,10.27,100,3.67
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,SNU-1,Auraptene,μM,48,hours,50,29.35,1.47,100,3.67
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,SNU-1,Auraptene,μM,48,hours,100,29.72,1.1,100,3.67
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,SNU-16,Auraptene,μM,48,hours,12.5,86.97,3.3,100,8.07
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,SNU-16,Auraptene,μM,48,hours,25,84.4,4.4,100,8.07
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,SNU-16,Auraptene,μM,48,hours,50,48.44,3.67,100,8.07
Moon et al.,2015,Gastric,Gastric Adenocarcinoma,SNU-16,Auraptene,μM,48,hours,100,44.03,4.41,100,8.07
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,24,hours,16.7,93.61,6.39,85.81,2.13
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,24,hours,33.4,85.81,2.13,85.81,2.13
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,24,hours,66.8,78.95,8.04,85.81,2.13
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,24,hours,133.6,52,11.35,85.81,2.13
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,48,hours,16.7,92.67,4.49,96.69,3.31
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,48,hours,33.4,79.9,5.2,96.69,3.31
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,48,hours,66.8,53.19,4.49,96.69,3.31
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,48,hours,133.6,37.58,5.91,96.69,3.31
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,72,hours,16.7,97.87,1.42,92.9,2.84
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,72,hours,33.4,91.48,6.62,92.9,2.84
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,72,hours,66.8,60.04,14.19,92.9,2.84
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,72,hours,133.6,44.2,5.44,92.9,2.84
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,96,hours,16.7,84.86,5.21,90.7,2.12
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,96,hours,33.4,69.97,4.26,90.7,2.12
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,96,hours,66.8,65.01,1,90.7,2.12
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,96,hours,133.6,43.26,3.54,90.7,2.12
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,120,hours,16.7,74.94,11.34,92.9,7.1
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,120,hours,33.4,72.1,10.16,92.9,7.1
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,120,hours,66.8,69.97,1,92.9,7.1
Movaffagh et al.,2021,Gastric,Gastric Carcinoma,MKN-45,Auraptene,μM,120,hours,133.6,41.13,5.67,92.9,7.1
Pulido-Capiz et al.,2024,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,35,92.86,3.2,100,2.22
Pulido-Capiz et al.,2024,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,50,32.27,6.4,100,2.22
Pulido-Capiz et al.,2024,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,75,22.41,1.48,100,2.22
Pulido-Capiz et al.,2024,Breast,Breast Adenocarcinoma,MCF-7,Auraptene,μM,48,hours,100,24.38,1.73,100,2.22
Shiran et al.,2021,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,6.25,94.44,2.96,100,1
Shiran et al.,2021,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,12.5,92.59,1.48,100,1
Shiran et al.,2021,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,25,87.03,3.34,100,1
Shiran et al.,2021,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,50,84.07,2.59,100,1
Shiran et al.,2021,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,100,58.14,2.6,100,1
Shiran et al.,2021,Breast,Breast Adenocarcinoma,MDA-MB-231,Auraptene,μM,24,hours,200,41.48,1.48,100,1
Suthiphasilp et al.,2022,Lung,Lung Adenocarcinoma,A549,Auraptene,μM,24,hours,6.25,99.08,1.08,100,1
Suthiphasilp et al.,2022,Lung,Lung Adenocarcinoma,A549,Auraptene,μM,24,hours,12.5,96.19,1.03,100,1
Suthiphasilp et al.,2022,Lung,Lung Adenocarcinoma,A549,Auraptene,μM,24,hours,25,41.03,1.64,100,1
Suthiphasilp et al.,2022,Lung,Lung Adenocarcinoma,A549,Auraptene,μM,24,hours,50,6.47,1,100,1
Suthiphasilp et al.,2022,Lung,Lung Adenocarcinoma,A549,Auraptene,μM,24,hours,100,5.21,1,100,1
Suthiphasilp et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,K562,Auraptene,μM,24,hours,6.25,82.72,1,100,1
Suthiphasilp et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,K562,Auraptene,μM,24,hours,12.5,78.88,1,100,1
Suthiphasilp et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,K562,Auraptene,μM,24,hours,25,64.25,2.02,100,1
Suthiphasilp et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,K562,Auraptene,μM,24,hours,50,33.18,1.11,100,1
Suthiphasilp et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,K562,Auraptene,μM,24,hours,100,24.88,1.02,100,1
Suthiphasilp et al.,2022,Colon,Colon Adenocarcinoma,SW480,Auraptene,μM,24,hours,6.25,99.46,1.4,100,1
Suthiphasilp et al.,2022,Colon,Colon Adenocarcinoma,SW480,Auraptene,μM,24,hours,12.5,95.07,2.47,100,1
Suthiphasilp et al.,2022,Colon,Colon Adenocarcinoma,SW480,Auraptene,μM,24,hours,25,75.78,1.49,100,1
Suthiphasilp et al.,2022,Colon,Colon Adenocarcinoma,SW480,Auraptene,μM,24,hours,50,46.24,2.17,100,1
Suthiphasilp et al.,2022,Colon,Colon Adenocarcinoma,SW480,Auraptene,μM,24,hours,100,5.71,1,100,1
Tang et al.,2007,Prostate,Prostate Carcinoma,DU145,Auraptene,μM,72,hours,230,66.62,8.5,100,19.04
Tang et al.,2007,Prostate,Prostate Carcinoma,DU145,Auraptene,μM,72,hours,250,60.16,10.88,100,19.04
Tang et al.,2007,Prostate,Prostate Carcinoma,DU145,Auraptene,μM,72,hours,270,41.47,10.54,100,19.04
Tang et al.,2007,Prostate,Prostate Carcinoma,DU145,Auraptene,μM,72,hours,290,13.59,5.1,100,19.04
Tang et al.,2007,Prostate,Prostate Carcinoma,LNCaP,Auraptene,μM,72,hours,230,78.64,5.76,100,11.63
Tang et al.,2007,Prostate,Prostate Carcinoma,LNCaP,Auraptene,μM,72,hours,250,75.59,6.78,100,11.63
Tang et al.,2007,Prostate,Prostate Carcinoma,LNCaP,Auraptene,μM,72,hours,270,55.25,8.47,100,11.63
Tang et al.,2007,Prostate,Prostate Carcinoma,LNCaP,Auraptene,μM,72,hours,290,47.11,17.29,100,11.63
Tang et al.,2007,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,72,hours,230,73.14,15.51,100,14.16
Tang et al.,2007,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,72,hours,250,58.98,7.08,100,14.16
Tang et al.,2007,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,72,hours,270,45.5,7.08,100,14.16
Tang et al.,2007,Prostate,Prostate Adenocarcinoma,PC-3,Auraptene,μM,72,hours,290,37.41,3.37,100,14.16
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,24,hours,100,80.2,4.26,100,1
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,24,hours,200,77.8,2.66,100,1
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,24,hours,300,72.2,5.6,100,1
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,24,hours,500,69.8,6.13,100,1
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,48,hours,100,46.36,5.59,100,1
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,48,hours,200,45.83,5.59,100,1
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,48,hours,300,43.69,8.26,100,1
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,48,hours,500,42.1,10.65,100,1
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,72,hours,100,41.56,6.93,100,1
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,72,hours,200,42.1,4.79,100,1
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,72,hours,300,38.63,4.27,100,1
Arora et al.,2016,Pancreatic,Pancreatic Adenocarcinoma,AsPc-1,Esculetin,μM,72,hours,500,34.9,5.33,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,24,hours,100,74.34,8.23,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,24,hours,200,57.88,10.08,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,24,hours,300,48.58,6.91,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,24,hours,500,43.81,9.55,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,48,hours,100,74.87,8.49,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,48,hours,200,41.15,3.72,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,48,hours,300,22.04,7.43,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,48,hours,500,17.52,6.9,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,72,hours,100,49.91,2.39,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,72,hours,200,32.92,4.78,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,72,hours,300,26.02,3.98,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,MIA-PACA-2 ,Esculetin,μM,72,hours,500,18.05,7.44,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,24,hours,100,68.5,9.82,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,24,hours,200,68.21,4.04,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,24,hours,300,59.83,7.8,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,24,hours,500,56.07,11.27,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,48,hours,100,55.49,10.98,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,48,hours,200,45.09,12.42,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,48,hours,300,42.49,10.11,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,48,hours,500,41.33,9.83,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,72,hours,100,42.2,9.25,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,72,hours,200,28.03,5.79,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,72,hours,300,25.43,6.07,100,1
Arora et al.,2016,Pancreatic,Pancreatic Carcinoma,PANC-1,Esculetin,μM,72,hours,500,20.23,10.69,100,1
Chang et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Esculetin,μM,24,hours,20,85.09,4.12,99.83,3.61
Chang et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Esculetin,μM,24,hours,40,57.88,3.61,99.83,3.61
Chang et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Esculetin,μM,24,hours,60,40.19,3.61,99.83,3.61
Chang et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Esculetin,μM,24,hours,80,32.01,3.61,99.83,3.61
Chang et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Esculetin,μM,24,hours,100,14.31,2.59,99.83,3.61
Chang et al.,2016,Breast,Breast Adenocarcinoma,MDA-MB-231,Esculetin,μM,24,hours,20,91.91,3.15,99.8,4.2
Chang et al.,2016,Breast,Breast Adenocarcinoma,MDA-MB-231,Esculetin,μM,24,hours,40,62.39,3.15,99.8,4.2
Chang et al.,2016,Breast,Breast Adenocarcinoma,MDA-MB-231,Esculetin,μM,24,hours,60,34.16,2.61,99.8,4.2
Chang et al.,2016,Breast,Breast Adenocarcinoma,MDA-MB-231,Esculetin,μM,24,hours,80,12.14,3.66,99.8,4.2
Chang et al.,2016,Breast,Breast Adenocarcinoma,MDA-MB-231,Esculetin,μM,24,hours,100,2.75,3.66,99.8,4.2
Chang et al.,2016,Breast,Breast Carcinoma,ZR-75-1,Esculetin,μM,24,hours,20,84.63,3.05,99.81,4.05
Chang et al.,2016,Breast,Breast Carcinoma,ZR-75-1,Esculetin,μM,24,hours,40,55.5,3.51,99.81,4.05
Chang et al.,2016,Breast,Breast Carcinoma,ZR-75-1,Esculetin,μM,24,hours,60,27.19,3.05,99.81,4.05
Chang et al.,2016,Breast,Breast Carcinoma,ZR-75-1,Esculetin,μM,24,hours,80,8.27,3.54,99.81,4.05
Chang et al.,2016,Breast,Breast Carcinoma,ZR-75-1,Esculetin,μM,24,hours,100,2.88,3.56,99.81,4.05
Cho et al.,2015,Oral,Squamous Carcinoma,HN22,Esculetin,μM,24,hours,14.03,93.67,1,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HN22,Esculetin,μM,24,hours,28.07,84.17,9.07,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HN22,Esculetin,μM,24,hours,56.14,50.5,7.77,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HN22,Esculetin,μM,24,hours,84.2,53.09,9.5,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HN22,Esculetin,μM,24,hours,112.27,50.07,8.2,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HN22,Esculetin,μM,48,hours,14.03,78.13,8.63,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HN22,Esculetin,μM,48,hours,28.07,65.18,9.06,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HN22,Esculetin,μM,48,hours,56.14,53.09,9.5,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HN22,Esculetin,μM,48,hours,84.2,40.14,9.93,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HN22,Esculetin,μM,48,hours,112.27,25.04,9.06,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HSC4,Esculetin,μM,24,hours,14.03,94.53,1,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HSC4,Esculetin,μM,24,hours,28.07,79.86,9.06,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HSC4,Esculetin,μM,24,hours,56.14,66.91,6.9,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HSC4,Esculetin,μM,24,hours,84.2,59.57,9.49,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HSC4,Esculetin,μM,24,hours,112.27,54.39,9.06,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HSC4,Esculetin,μM,48,hours,14.03,74.68,9.92,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HSC4,Esculetin,μM,48,hours,28.07,59.57,8.2,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HSC4,Esculetin,μM,48,hours,56.14,48.35,8.63,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HSC4,Esculetin,μM,48,hours,84.2,40.58,7.77,100,1
Cho et al.,2015,Oral,Squamous Carcinoma,HSC4,Esculetin,μM,48,hours,112.27,31.08,9.93,100,1
Choi et al.,2019,Colon,Colon Adenocarcinoma,LoVo,Esculetin,μM,24,hours,200,72.15,3.68,100,1
Choi et al.,2019,Colon,Colon Adenocarcinoma,LoVo,Esculetin,μM,48,hours,200,56.87,3.13,100,1
Choi et al.,2019,Colon,Colon Adenocarcinoma,LoVo,Esculetin,μM,72,hours,200,16.93,7.92,100,1
Choi et al.,2019,Colon,Colon Adenocarcinoma,LoVo,Esculetin,μM,24,hours,400,63.13,4.23,100,1
Choi et al.,2019,Colon,Colon Adenocarcinoma,LoVo,Esculetin,μM,48,hours,400,49.69,1.29,100,1
Choi et al.,2019,Colon,Colon Adenocarcinoma,LoVo,Esculetin,μM,72,hours,400,13.44,4.04,100,1
Choi et al.,2019,Colon,Colon Adenocarcinoma,LoVo,Esculetin,μM,24,hours,600,56.13,4.24,100,1
Choi et al.,2019,Colon,Colon Adenocarcinoma,LoVo,Esculetin,μM,48,hours,600,32.94,3.32,100,1
Choi et al.,2019,Colon,Colon Adenocarcinoma,LoVo,Esculetin,μM,72,hours,600,11.41,2.39,100,1
Duan et al.,2020,Renal,Renal Adenocarcinoma,786-O,Esculetin,μM,24,hours,140.34,98.78,5.79,100,1
Duan et al.,2020,Renal,Renal Adenocarcinoma,786-O,Esculetin,μM,24,hours,280.68,63.28,2.31,100,1
Duan et al.,2020,Renal,Renal Adenocarcinoma,786-O,Esculetin,μM,24,hours,561.36,57.88,1.93,100,1
Duan et al.,2020,Renal,Renal Adenocarcinoma,786-O,Esculetin,μM,24,hours,1122.71,42.06,1.93,100,1
Duan et al.,2020,Renal,Renal Adenocarcinoma,786-O,Esculetin,μM,48,hours,70.17,80.26,1.54,100,1
Duan et al.,2020,Renal,Renal Adenocarcinoma,786-O,Esculetin,μM,48,hours,140.34,70.61,2.7,100,1
Duan et al.,2020,Renal,Renal Adenocarcinoma,786-O,Esculetin,μM,48,hours,280.68,51.7,2.32,100,1
Duan et al.,2020,Renal,Renal Adenocarcinoma,786-O,Esculetin,μM,48,hours,561.36,30.87,1,100,1
Duan et al.,2020,Renal,Renal Adenocarcinoma,786-O,Esculetin,μM,48,hours,1122.71,26.24,1.54,100,1
Duan et al.,2020,Renal,Renal Carcinoma,SN12-PM6,Esculetin,μM,24,hours,70.17,93.38,3.47,100,1
Duan et al.,2020,Renal,Renal Carcinoma,SN12-PM6,Esculetin,μM,24,hours,140.34,94.92,2.7,100,1
Duan et al.,2020,Renal,Renal Carcinoma,SN12-PM6,Esculetin,μM,24,hours,280.68,84.12,3.85,100,1
Duan et al.,2020,Renal,Renal Carcinoma,SN12-PM6,Esculetin,μM,24,hours,561.36,74.08,2.7,100,1
Duan et al.,2020,Renal,Renal Carcinoma,SN12-PM6,Esculetin,μM,24,hours,1122.71,55.56,3.86,100,1
Duan et al.,2020,Renal,Renal Carcinoma,SN12-PM6,Esculetin,μM,48,hours,70.17,88.36,1.93,100,1
Duan et al.,2020,Renal,Renal Carcinoma,SN12-PM6,Esculetin,μM,48,hours,140.34,79.49,1.92,100,1
Duan et al.,2020,Renal,Renal Carcinoma,SN12-PM6,Esculetin,μM,48,hours,280.68,66.75,3.86,100,1
Duan et al.,2020,Renal,Renal Carcinoma,SN12-PM6,Esculetin,μM,48,hours,561.36,57.49,3.47,100,1
Duan et al.,2020,Renal,Renal Carcinoma,SN12-PM6,Esculetin,μM,48,hours,1122.71,45.14,1,100,1
Jeon et al.,2016,Oral,Squamous Carcinoma,HN22,Esculetin,μM,24,hours,28.07,88.59,1.41,99.84,1.41
Jeon et al.,2016,Oral,Squamous Carcinoma,HN22,Esculetin,μM,24,hours,56.14,57.66,1.4,99.84,1.41
Jeon et al.,2016,Oral,Squamous Carcinoma,HN22,Esculetin,μM,24,hours,112.27,30,1.41,99.84,1.41
Jeon et al.,2016,Oral,Squamous Carcinoma,HN22,Esculetin,μM,48,hours,28.07,73.13,1,100.31,1
Jeon et al.,2016,Oral,Squamous Carcinoma,HN22,Esculetin,μM,48,hours,56.14,50.16,1,100.31,1
Jeon et al.,2016,Oral,Squamous Carcinoma,HN22,Esculetin,μM,48,hours,112.27,25.78,1,100.31,1
Jeon et al.,2016,Oral,Squamous Carcinoma,HSC2,Esculetin,μM,24,hours,28.07,81.56,7.5,100.31,4.22
Jeon et al.,2016,Oral,Squamous Carcinoma,HSC2,Esculetin,μM,24,hours,56.14,70.31,7.03,100.31,4.22
Jeon et al.,2016,Oral,Squamous Carcinoma,HSC2,Esculetin,μM,24,hours,112.27,45.94,6.09,100.31,4.22
Jeon et al.,2016,Oral,Squamous Carcinoma,HSC2,Esculetin,μM,48,hours,28.07,59.06,1.41,100.78,2.81
Jeon et al.,2016,Oral,Squamous Carcinoma,HSC2,Esculetin,μM,48,hours,56.14,49.22,1,100.78,2.81
Jeon et al.,2016,Oral,Squamous Carcinoma,HSC2,Esculetin,μM,48,hours,112.27,30.47,1,100.78,2.81
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,24,hours,0.01,92.63,8.35,100,1
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,24,hours,0.1,85.12,6.92,100,1
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,24,hours,1,93.31,13.62,100,1
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,24,hours,10,82.39,12.57,100,1
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,24,hours,30,81.98,21.39,100,1
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,24,hours,100,52.42,12.37,100,1
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,48,hours,0.01,98.54,2.31,100,1
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,48,hours,0.1,98.96,2.1,100,1
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,48,hours,1,100,4.4,100,1
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,48,hours,10,92.25,6.29,100,1
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,48,hours,30,71.07,3.77,100,1
Khunluck et al.,2018,Cholangiocarcinoma,Cholangiocarcinoma,KKU-100,Esculetin,μM,48,hours,100,24.53,2.93,100,1
Kim et al.,2015,Colon,Colon Adenocarcinoma,HT-29,Esculetin,μM,48,hours,112.27,97.07,1.58,100.03,2.18
Kim et al.,2015,Colon,Colon Adenocarcinoma,HT-29,Esculetin,μM,48,hours,224.54,61.09,3.95,100.03,2.18
Kim et al.,2015,Colon,Colon Adenocarcinoma,HT-29,Esculetin,μM,48,hours,336.81,45.07,1.78,100.03,2.18
Kim et al.,2015,Colon,Colon Adenocarcinoma,HT-29,Esculetin,μM,48,hours,449.08,32.82,1.18,100.03,2.18
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,24,hours,20,98.84,2.24,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,24,hours,40,90.62,1.25,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,24,hours,60,64.73,5.48,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,24,hours,80,45.56,3.24,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,24,hours,100,32.37,2.24,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,48,hours,20,97.1,3.73,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,48,hours,40,67.47,3.48,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,48,hours,60,42.07,5.98,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,48,hours,80,16.43,2.24,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,48,hours,100,11.95,1.49,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,72,hours,20,84.65,5.97,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,72,hours,40,66.22,4.49,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,72,hours,60,27.88,1,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,72,hours,80,13.69,1.5,100,1
Kim et al.,2018,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,72,hours,100,9.46,1.49,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,24,hours,20,100,1.9,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,24,hours,40,94.76,3.81,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,24,hours,60,75.48,2.62,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,24,hours,80,63.57,5,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,24,hours,100,49.52,4.05,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,48,hours,20,95.24,4.76,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,48,hours,40,85.24,2.14,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,48,hours,60,67.38,5.24,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,48,hours,80,46.43,5.71,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,48,hours,100,30.95,2.86,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,72,hours,20,90.48,2.62,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,72,hours,40,84.76,5.24,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,72,hours,60,52.38,3.33,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,72,hours,80,33.1,1,100,1
Kim et al.,2018,Colon,Colon Adenocarcinoma,SW480,Esculetin,μM,72,hours,100,24.29,2.61,100,1
Lee et al.,2013,Colon,Colon Adenocarcinoma,DLD-1,Esculetin,μM,72,hours,20,93.52,1.99,99.74,1
Lee et al.,2013,Colon,Colon Adenocarcinoma,DLD-1,Esculetin,μM,72,hours,40,67.22,3.75,99.74,1
Lee et al.,2013,Colon,Colon Adenocarcinoma,DLD-1,Esculetin,μM,72,hours,60,55.48,2.43,99.74,1
Lee et al.,2013,Colon,Colon Adenocarcinoma,DLD-1,Esculetin,μM,72,hours,80,43.96,3.09,99.74,1
Lee et al.,2013,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,72,hours,20,84.88,4.88,99.76,6.98
Lee et al.,2013,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,72,hours,40,67.67,6.98,99.76,6.98
Lee et al.,2013,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,72,hours,60,49.53,6.51,99.76,6.98
Lee et al.,2013,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,72,hours,80,33.02,3.25,99.76,6.98
Lee et al.,2013,Colon,Colon Adenocarcinoma,HCT-15,Esculetin,μM,72,hours,20,91.12,12.71,100,11.08
Lee et al.,2013,Colon,Colon Adenocarcinoma,HCT-15,Esculetin,μM,72,hours,40,72.34,7.06,100,11.08
Lee et al.,2013,Colon,Colon Adenocarcinoma,HCT-15,Esculetin,μM,72,hours,60,48.62,8.94,100,11.08
Lee et al.,2013,Colon,Colon Adenocarcinoma,HCT-15,Esculetin,μM,72,hours,80,30.79,3.53,100,11.08
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H1299,Esculetin,μM,24,hours,140.34,77.96,2.45,100.82,1
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H1299,Esculetin,μM,24,hours,280.68,61.22,2.05,100.82,1
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H1299,Esculetin,μM,24,hours,561.36,49.39,2.85,100.82,1
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H1299,Esculetin,μM,24,hours,842.03,42.86,3.26,100.82,1
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H1299,Esculetin,μM,48,hours,140.34,69.8,1.63,100.82,1
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H1299,Esculetin,μM,48,hours,280.68,57.14,1.64,100.82,1
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H1299,Esculetin,μM,48,hours,561.36,38.78,2.44,100.82,1
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H1299,Esculetin,μM,48,hours,842.03,24.08,4.49,100.82,1
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H358,Esculetin,μM,24,hours,140.34,87.35,1.22,100,1.22
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H358,Esculetin,μM,24,hours,280.68,62.86,2.04,100,1.22
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H358,Esculetin,μM,24,hours,561.36,56.73,3.27,100,1.22
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H358,Esculetin,μM,24,hours,842.03,41.63,4.08,100,1.22
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H358,Esculetin,μM,48,hours,140.34,65.71,2.86,99.59,1.23
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H358,Esculetin,μM,48,hours,280.68,43.27,1.63,99.59,1.23
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H358,Esculetin,μM,48,hours,561.36,36.73,2.86,99.59,1.23
Lee et al.,2017,Lung,Lung Carcinoma,NCI-H358,Esculetin,μM,48,hours,842.03,24.9,1.63,99.59,1.23
Lee et al.,2017,Liver,Liver Carcinoma,HepG2,Esculetin,μM,24,hours,50,97.72,4.89,100.07,2.14
Lee et al.,2017,Liver,Liver Carcinoma,HepG2,Esculetin,μM,24,hours,100,99.09,2.93,100.07,2.14
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,24,hours,2.54,93.19,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,24,hours,4.98,85.26,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,24,hours,9.95,64.65,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,24,hours,20.01,50.66,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,24,hours,40.02,48.39,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,36,hours,2.49,86.96,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,36,hours,5.03,77.13,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,36,hours,10.06,55.39,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,36,hours,20.07,38.19,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,36,hours,40.08,32.89,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,48,hours,2.54,82.42,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,48,hours,5.03,70.32,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,48,hours,10.11,46.88,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,48,hours,20.01,29.3,1,100,1
Li et al.,2019,Lung,Lung Adenocarcinoma,A549,Esculetin,μM,48,hours,40.02,23.06,1,100,1
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,24,hours,12.5,87.89,2.34,100,3.01
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,24,hours,25,75.79,2.34,100,3.01
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,24,hours,50,60.68,1.68,100,3.01
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,24,hours,100,48.59,2.67,100,3.01
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,24,hours,150,33.15,2.34,100,3.01
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,48,hours,12.5,83.19,3.68,100,3.67
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,48,hours,25,67.08,3.68,100,3.67
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,48,hours,50,54.98,4.69,100,3.67
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,48,hours,100,43.89,4.02,100,3.67
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,48,hours,150,25.11,3.68,100,3.67
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,72,hours,12.5,79.16,2.68,100,3.67
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,72,hours,25,58.37,3.34,100,3.67
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,72,hours,50,51.96,4.01,100,3.67
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,72,hours,100,40.2,3.68,100,3.67
Pan et al.,2015,Gastric,Gastric Adenocarcinoma,BGC-823,Esculetin,μM,72,hours,150,23.08,4.35,100,3.67
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,3,hours,56.14,97.86,4.08,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,3,hours,112.27,94.95,3.5,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,3,hours,168.41,88.54,3.5,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,3,hours,224.54,80.39,2.91,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,3,hours,280.68,73.98,3.5,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,6,hours,56.14,96.7,2.91,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,6,hours,112.27,84.47,1,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,6,hours,168.41,57.67,4.08,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,6,hours,224.54,43.69,4.08,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,6,hours,280.68,36.7,2.33,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,12,hours,56.14,92.04,2.33,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,12,hours,112.27,75.73,4.66,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,12,hours,168.41,34.95,4.66,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,12,hours,224.54,18.64,4.08,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,12,hours,280.68,13.98,4.08,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,24,hours,56.14,83.3,3.5,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,24,hours,112.27,3.5,3.49,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,24,hours,168.41,18.64,3.5,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,24,hours,224.54,9.32,4.08,100,1
Park et al.,2010,Leukemia/Lymphoma,Leukemia/Lymphoma,U937,Esculetin,μM,24,hours,280.68,5.83,4.66,100,1
Park et al.,2011,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,24,hours,140.34,79.37,6.95,95.07,4.03
Park et al.,2011,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,24,hours,280.68,60.31,3.14,95.07,4.03
Park et al.,2011,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,24,hours,561.36,43.5,5.15,95.07,4.03
Park et al.,2011,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,24,hours,1122.71,21.75,6.28,95.07,4.03
Park et al.,2011,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,6,hours,561.36,77.84,4.99,99.3,5.49
Park et al.,2011,Colon,Colon Carcinoma,HCT-116,Esculetin,μM,12,hours,561.36,58.38,4.49,99.3,5.49
Park et al.,2022,Salivary Gland,Squamous Carcinoma,A253,Esculetin,μM,24,hours,50,88.4,2.8,96.4,6
Park et al.,2022,Salivary Gland,Squamous Carcinoma,A253,Esculetin,μM,24,hours,100,68.4,1.6,96.4,6
Park et al.,2022,Salivary Gland,Squamous Carcinoma,A253,Esculetin,μM,24,hours,150,53.2,4,96.4,6
Park et al.,2022,Salivary Gland,Squamous Carcinoma,A253,Esculetin,μM,48,hours,50,61.2,2.8,95.2,4.4
Park et al.,2022,Salivary Gland,Squamous Carcinoma,A253,Esculetin,μM,48,hours,100,36.4,1.2,95.2,4.4
Park et al.,2022,Salivary Gland,Squamous Carcinoma,A253,Esculetin,μM,48,hours,150,30,3.2,95.2,4.4
Turkekul et al.,2018,Prostate,Prostate Carcinoma,DU145,Esculetin,μM,48,hours,25,93.66,1.25,99.93,2.09
Turkekul et al.,2018,Prostate,Prostate Carcinoma,DU145,Esculetin,μM,48,hours,75,69.83,1.67,99.93,2.09
Turkekul et al.,2018,Prostate,Prostate Carcinoma,DU145,Esculetin,μM,48,hours,150,62.3,1.67,99.93,2.09
Turkekul et al.,2018,Prostate,Prostate Carcinoma,DU145,Esculetin,μM,48,hours,300,53.1,1.67,99.93,2.09
Turkekul et al.,2018,Prostate,Prostate Carcinoma,LNCaP,Esculetin,μM,48,hours,25,82.79,1.25,100.35,2.09
Turkekul et al.,2018,Prostate,Prostate Carcinoma,LNCaP,Esculetin,μM,48,hours,75,61.46,1.26,100.35,2.09
Turkekul et al.,2018,Prostate,Prostate Carcinoma,LNCaP,Esculetin,μM,48,hours,150,54.77,1.26,100.35,2.09
Turkekul et al.,2018,Prostate,Prostate Carcinoma,LNCaP,Esculetin,μM,48,hours,300,53.1,1.26,100.35,2.09
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,24,hours,9.4,91.15,4.18,99.93,2.93
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,24,hours,18.8,89.06,7.11,99.93,2.93
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,24,hours,37.5,88.64,5.85,99.93,2.93
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,24,hours,75,85.3,4.6,99.93,2.93
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,24,hours,150,82.37,6.27,99.93,2.93
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,24,hours,300,80.7,5.01,99.93,2.93
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,24,hours,600,69.83,8.36,99.93,2.93
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,48,hours,9.4,90.31,5.44,100.35,3.34
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,48,hours,18.8,81.11,10.04,100.35,3.34
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,48,hours,37.5,70.66,5.86,100.35,3.34
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,48,hours,75,56.86,5.86,100.35,3.34
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,48,hours,150,53.1,5.85,100.35,3.34
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,48,hours,300,38.89,3.76,100.35,3.34
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,48,hours,600,35.54,5.44,100.35,3.34
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,72,hours,9.4,91.15,2.93,99.93,5.02
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,72,hours,18.8,68.15,7.95,99.93,5.02
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,72,hours,37.5,48.08,6.69,99.93,5.02
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,72,hours,75,35.96,4.18,99.93,5.02
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,72,hours,150,28.85,2.93,99.93,5.02
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,72,hours,300,25.92,3.77,99.93,5.02
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,72,hours,600,19.23,2.93,99.93,5.02
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,48,hours,25,83.21,5.85,99.93,3.76
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,48,hours,75,56.86,6.28,99.93,3.76
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,48,hours,150,52.68,6.69,99.93,3.76
Turkekul et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Esculetin,μM,48,hours,300,38.47,4.6,99.93,3.76
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,24,hours,140,91.95,5.49,97.92,1.3
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,24,hours,280,84.95,5.74,97.92,1.3
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,24,hours,560,78.47,7.57,97.92,1.3
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,24,hours,850,57.62,6.27,97.92,1.3
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,48,hours,140,89.88,4.7,97.14,1.57
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,48,hours,280,86.27,5.74,97.14,1.57
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,48,hours,560,75.6,7.03,97.14,1.57
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,48,hours,850,57.89,6.01,97.14,1.57
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,72,hours,140,89.1,4.44,99.51,2.08
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,72,hours,280,82.36,7.31,99.51,2.08
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,72,hours,560,60.56,5.29,99.51,2.08
Wang et al.,2017,Gastric,Gastric Carcinoma,HGC-27,Esculetin,μM,72,hours,850,62.34,5.49,99.51,2.08
Wroblewska-Luczka et al.,2023,Skin,Melanoma,A375,Esculetin,μM,72,hours,10,94.49,14.79,100,16.21
Wroblewska-Luczka et al.,2023,Skin,Melanoma,A375,Esculetin,μM,72,hours,20,80.16,16.23,100,16.21
Wroblewska-Luczka et al.,2023,Skin,Melanoma,A375,Esculetin,μM,72,hours,40,71.62,8.11,100,16.21
Wroblewska-Luczka et al.,2023,Skin,Melanoma,A375,Esculetin,μM,72,hours,50,62.53,1.54,100,16.21
Wroblewska-Luczka et al.,2023,Skin,Melanoma,A375,Esculetin,μM,72,hours,60,57.57,13.84,100,16.21
Wroblewska-Luczka et al.,2023,Skin,Melanoma,A375,Esculetin,μM,72,hours,100,29.75,7.15,100,16.21
Wroblewska-Luczka et al.,2023,Skin,Melanoma,A375,Esculetin,μM,72,hours,150,25.89,8.59,100,16.21
Wroblewska-Luczka et al.,2023,Skin,Melanoma,A375,Esculetin,μM,72,hours,200,27.27,6.67,100,16.21
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55M2,Esculetin,μM,72,hours,2,89.58,10.44,100,16.59
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55M2,Esculetin,μM,72,hours,10,70.41,7.12,100,16.59
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55M2,Esculetin,μM,72,hours,20,46.84,6.18,100,16.59
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55M2,Esculetin,μM,72,hours,40,22.73,7.12,100,16.59
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55M2,Esculetin,μM,72,hours,50,18.9,5.72,100,16.59
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55M2,Esculetin,μM,72,hours,60,18.63,5.21,100,16.59
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55M2,Esculetin,μM,72,hours,100,19.17,5.23,100,16.59
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55M2,Esculetin,μM,72,hours,150,15.61,3.33,100,16.59
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55M2,Esculetin,μM,72,hours,200,13.97,3.33,100,16.59
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55P,Esculetin,μM,72,hours,2,92.68,8.92,99.72,6.11
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55P,Esculetin,μM,72,hours,10,78.04,8.45,99.72,6.11
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55P,Esculetin,μM,72,hours,20,57.72,9.39,99.72,6.11
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55P,Esculetin,μM,72,hours,40,34.39,4.69,99.72,6.11
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55P,Esculetin,μM,72,hours,50,31.43,6.1,99.72,6.11
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55P,Esculetin,μM,72,hours,60,28.45,5.16,99.72,6.11
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55P,Esculetin,μM,72,hours,100,21.4,5.18,99.72,6.11
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55P,Esculetin,μM,72,hours,150,21.4,4.69,99.72,6.11
Wroblewska-Luczka et al.,2023,Skin,Melanoma,FM55P,Esculetin,μM,72,hours,200,21.95,6.1,99.72,6.11
Wroblewska-Luczka et al.,2023,Skin,Melanoma,SK-MEL-28,Esculetin,μM,72,hours,2,96.16,10.63,100,8.4
Wroblewska-Luczka et al.,2023,Skin,Melanoma,SK-MEL-28,Esculetin,μM,72,hours,10,94.37,12.85,100,8.4
Wroblewska-Luczka et al.,2023,Skin,Melanoma,SK-MEL-28,Esculetin,μM,72,hours,20,81.84,7.52,100,8.4
Wroblewska-Luczka et al.,2023,Skin,Melanoma,SK-MEL-28,Esculetin,μM,72,hours,40,68.03,15.93,100,8.4
Wroblewska-Luczka et al.,2023,Skin,Melanoma,SK-MEL-28,Esculetin,μM,72,hours,50,66.24,13.72,100,8.4
Wroblewska-Luczka et al.,2023,Skin,Melanoma,SK-MEL-28,Esculetin,μM,72,hours,60,66.24,16.82,100,8.4
Wroblewska-Luczka et al.,2023,Skin,Melanoma,SK-MEL-28,Esculetin,μM,72,hours,100,53.45,9.79,100,8.4
Wroblewska-Luczka et al.,2023,Skin,Melanoma,SK-MEL-28,Esculetin,μM,72,hours,150,43.47,11.97,100,8.4
Wroblewska-Luczka et al.,2023,Skin,Melanoma,SK-MEL-28,Esculetin,μM,72,hours,200,39.89,16.84,100,8.4
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,1,hours,25,99.53,5.68,100,1
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,1,hours,100,98.82,5.68,100,1
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,1,hours,25,98.82,2.13,100,1
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,1,hours,50,95.97,3.56,100,1
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,1,hours,100,73.93,2.14,100,1
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,1,hours,200,56.16,2.13,100,1
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,1,hours,100,44.08,2.84,100,1
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,1,hours,200,36.26,2.84,100,1
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,8,hours,25,78.47,3.47,100,1
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,8,hours,50,59.72,4.17,100,1
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,8,hours,100,54.17,2.08,100,1
Wu et al.,2020,Liver,Liver Carcinoma,HepG2,Esculetin,μM,8,hours,200,45.14,4.86,100,1
Afsharzadeh et al.,2020,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,48,hours,120,26.13,1.07,100,1
Afsharzadeh et al.,2020,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,48,hours,100,42.66,2.14,100,1
Afsharzadeh et al.,2020,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,48,hours,60,63.19,2.14,100,1
Afsharzadeh et al.,2020,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,48,hours,40,76.8,1.6,100,1
Afsharzadeh et al.,2020,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,48,hours,20,93.86,2.94,100,1
Afsharzadeh et al.,2020,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,48,hours,120,45.13,4.72,100,1
Afsharzadeh et al.,2020,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,48,hours,100,51.62,3.83,100,1
Afsharzadeh et al.,2020,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,48,hours,80,71.09,3.83,100,1
Afsharzadeh et al.,2020,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,48,hours,60,75.22,5.31,100,1
Afsharzadeh et al.,2020,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,48,hours,40,85.25,4.72,100,1
Afsharzadeh et al.,2020,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,48,hours,20,97.34,3.54,100,1
Ahmadi et al.,2025,Bone,Osteosarcoma,MG-63,Galbanic Acid,μM,24,hours,25,95.5,6.69,96,5.64
Ahmadi et al.,2025,Bone,Osteosarcoma,MG-63,Galbanic Acid,μM,24,hours,50,92.5,6.46,96,5.64
Ahmadi et al.,2025,Bone,Osteosarcoma,MG-63,Galbanic Acid,μM,24,hours,100,80.5,2.11,96,5.64
Ahmadi et al.,2025,Bone,Osteosarcoma,MG-63,Galbanic Acid,μM,48,hours,25,93.6,0.35,95,7.16
Ahmadi et al.,2025,Bone,Osteosarcoma,MG-63,Galbanic Acid,μM,48,hours,50,90.6,9.16,95,7.16
Ahmadi et al.,2025,Bone,Osteosarcoma,MG-63,Galbanic Acid,μM,48,hours,100,80.6,13.27,95,7.16
Chahardoli et al.,2022,Lung,Lung Adenocarcinoma,H1229,Galbanic Acid,μM,48,hours,25.1,80.45,3.38,99.72,1
Chahardoli et al.,2022,Lung,Lung Adenocarcinoma,H1229,Galbanic Acid,μM,48,hours,62.7,57.8,4.74,99.72,1
Chahardoli et al.,2022,Lung,Lung Adenocarcinoma,H1229,Galbanic Acid,μM,48,hours,125.4,27.72,4.39,99.72,1
Chahardoli et al.,2022,Lung,Lung Adenocarcinoma,H1229,Galbanic Acid,μM,48,hours,250.8,8.79,1.01,99.72,1
Chahardoli et al.,2022,Lung,Lung Adenocarcinoma,H1229,Galbanic Acid,μM,48,hours,376.2,0.68,1.01,99.72,1
Chahardoli et al.,2022,Breast,Breast Adenocarcinoma,MCF-7,Galbanic Acid,μM,48,hours,25.1,89.58,1,99.38,1
Chahardoli et al.,2022,Breast,Breast Adenocarcinoma,MCF-7,Galbanic Acid,μM,48,hours,62.7,89.58,1,99.38,1
Chahardoli et al.,2022,Breast,Breast Adenocarcinoma,MCF-7,Galbanic Acid,μM,48,hours,125.4,66.25,1.02,99.38,1
Chahardoli et al.,2022,Breast,Breast Adenocarcinoma,MCF-7,Galbanic Acid,μM,48,hours,250.8,62.87,1,99.38,1
Chahardoli et al.,2022,Breast,Breast Adenocarcinoma,MCF-7,Galbanic Acid,μM,48,hours,376.2,44.62,1,99.38,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,24,hours,150,34.72,2.79,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,48,hours,150,30.07,NA,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,72,hours,150,18.91,2.79,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,24,hours,100,40.31,2.79,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,48,hours,100,37.51,NA,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,72,hours,100,26.97,1.86,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,24,hours,50,44.65,2.48,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,48,hours,50,43.72,NA,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,72,hours,50,34.72,4.34,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,24,hours,25,52.4,2.17,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,48,hours,25,48.06,NA,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,72,hours,25,41.24,NA,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,24,hours,12.5,66.66,3.72,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,48,hours,12.5,62,NA,100,1
Eskandani et al.,2015,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,72,hours,12.5,58,NA,100,1
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,24,hours,100,6.05,7.35,90.66,8.98
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,48,hours,100,16.67,9.39,96.38,3.62
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,72,hours,100,2.39,2.86,95.98,4.02
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,24,hours,50,31.26,21.64,90.66,8.98
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,48,hours,50,55.78,6.53,96.38,3.62
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,72,hours,50,32.93,8.98,95.98,4.02
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,24,hours,25,71.21,4.08,90.66,8.98
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,48,hours,25,90.4,8.98,96.38,3.62
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,72,hours,25,85.1,14.7,95.98,4.02
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,24,hours,12.5,87.47,8.57,90.66,8.98
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,48,hours,12.5,92.37,7.63,96.38,3.62
Farahi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Galbanic Acid,μM,72,hours,12.5,85.03,10.61,95.98,4.02
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,48,hours,20,94.4,10.08,100.46,2.79
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,72,hours,20,96,3.55,100.46,2.79
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,96,hours,20,93.8,5.3,100.46,2.79
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,48,hours,10,97.4,4.84,100.46,2.79
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,72,hours,10,92.2,1,100.46,2.79
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,96,hours,10,93,1.17,100.46,2.79
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,24,hours,100,4.94,5.33,92.58,7.11
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,48,hours,100,13.86,11.38,96.16,4.27
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,72,hours,100,9.96,6.4,96.18,4.62
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,24,hours,50,22.67,11.74,92.58,7.11
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,48,hours,50,72.87,6.05,96.16,4.27
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,72,hours,50,56.51,12.81,96.18,4.62
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,24,hours,25,73.14,20.64,92.58,7.11
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,48,hours,25,82.77,1.77,96.16,4.27
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,72,hours,25,68.91,2.84,96.18,4.62
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,24,hours,12.5,85.89,12.81,92.58,7.11
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,48,hours,12.5,92.31,7.82,96.16,4.27
Hashemi et al.,2021,Ovarian,Ovarian Adenocarcinoma,OVCAR-3,Galbanic Acid,μM,72,hours,12.5,86.63,17.43,96.18,4.62
Hashemi et al.,2021,Colon,Colon Adenocarcinoma,C26,Galbanic Acid,μM,48,hours,1.25,79.56,2.58,100,1
Hashemi et al.,2021,Colon,Colon Adenocarcinoma,C26,Galbanic Acid,μM,48,hours,2.5,71.83,1.58,100,1
Hashemi et al.,2021,Colon,Colon Adenocarcinoma,C26,Galbanic Acid,μM,48,hours,5,65.08,1.98,100,1
Hashemi et al.,2021,Colon,Colon Adenocarcinoma,C26,Galbanic Acid,μM,48,hours,10,52.98,2.18,100,1
Hashemi et al.,2021,Colon,Colon Adenocarcinoma,C26,Galbanic Acid,μM,48,hours,20,40.08,2.18,100,1
Hashemi et al.,2021,Colon,Colon Adenocarcinoma,C26,Galbanic Acid,μM,48,hours,40,10.52,1.58,100,1
Jafari et al.,2018,Colon,Colon Adenocarcinoma,Caco-2,Galbanic Acid,μM,48,hours,256,53.36,4.47,100,1
Jafari et al.,2018,Colon,Colon Adenocarcinoma,Caco-2,Galbanic Acid,μM,48,hours,234,73.47,3.91,100,1
Jafari et al.,2018,Colon,Colon Adenocarcinoma,Caco-2,Galbanic Acid,μM,48,hours,211,83.8,NA,100,1
Jafari et al.,2018,Colon,Colon Adenocarcinoma,Caco-2,Galbanic Acid,μM,48,hours,176,87.16,4.47,100,1
Jafari et al.,2018,Colon,Colon Adenocarcinoma,Caco-2,Galbanic Acid,μM,48,hours,115,87.71,5.02,100,1
Jafari et al.,2018,Colon,Colon Adenocarcinoma,Caco-2,Galbanic Acid,μM,48,hours,56,91.63,2.8,100,1
Kim et al.,2019,Lung,Lung,H460,Galbanic Acid,μM,24,hours,800,15.99,NA,100,1
Kim et al.,2019,Lung,Lung,H460,Galbanic Acid,μM,24,hours,400,22.8,NA,100,1
Kim et al.,2019,Lung,Lung,H460,Galbanic Acid,μM,24,hours,200,43.4,2.29,100,1
Kim et al.,2019,Lung,Lung,H460,Galbanic Acid,μM,24,hours,100,54.5,1.96,100,1
Kim et al.,2019,Lung,Lung,H460,Galbanic Acid,μM,24,hours,75,61.35,NA,100,1
Kim et al.,2019,Lung,Lung,H460,Galbanic Acid,μM,24,hours,50,73.1,NA,100,1
Kim et al.,2019,Lung,Lung,H460,Galbanic Acid,μM,24,hours,25,80.61,6.53,100,1
Kim et al.,2019,Lung,Lung,H460,Galbanic Acid,μM,24,hours,12.5,94.32,NA,100,1
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,24,hours,5,99.09,1,99.77,1
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,48,hours,5,98.18,1.95,99.77,1
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,72,hours,5,97.95,2.2,98.86,2.2
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,24,hours,10,97.27,2.93,99.77,1
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,48,hours,10,93.41,4.15,99.77,1
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,72,hours,10,95.45,6.6,98.86,2.2
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,24,hours,20,93.86,5.38,99.77,1
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,48,hours,20,89.09,2.44,99.77,1
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,72,hours,20,92.5,4.4,98.86,2.2
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,24,hours,40,93.18,6.6,99.77,1
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,48,hours,40,71.3,8.31,99.77,1
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,72,hours,40,88.18,10.76,98.86,2.2
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,24,hours,80,82.6,4.15,99.77,1
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,48,hours,80,53.3,5.14,99.77,1
Mahdifar et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Galbanic Acid,μM,72,hours,80,78,5.86,98.86,2.2
Mohtashami et al.,2018,Prostate,Prostate Carcinoma,DU145,Galbanic Acid,μM,72,hours,125.46,94.23,3.39,99.32,2.71
Mohtashami et al.,2018,Prostate,Prostate Carcinoma,DU145,Galbanic Acid,μM,72,hours,62.73,93.22,2.71,99.32,2.71
Mohtashami et al.,2018,Prostate,Prostate Carcinoma,DU145,Galbanic Acid,μM,72,hours,25.1,94.57,1.7,99.32,2.71
Mohtashami et al.,2018,Prostate,Prostate Carcinoma,DU145,Galbanic Acid,μM,72,hours,2.51,96.27,1.69,99.32,2.71
Mohtashami et al.,2018,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,72,hours,125.46,68.77,1.99,99.33,1.33
Mohtashami et al.,2018,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,72,hours,62.73,96.67,1.66,99.33,1.33
Mohtashami et al.,2018,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,72,hours,25.1,96.34,2.66,99.33,1.33
Mohtashami et al.,2018,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,72,hours,2.51,98,2,99.33,1.33
Mohtashami et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,72,hours,125.46,96.1,3.12,100,1.55
Mohtashami et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,72,hours,62.73,95.71,2.34,100,1.55
Mohtashami et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,72,hours,25.1,96.88,2.73,100,1.55
Mohtashami et al.,2018,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,72,hours,2.51,98.44,1.17,100,1.55
Sajjadi et al.,2019,Breast,Breast Adenocarcinoma,MCF-7,Galbanic Acid,μM,48,hours,627.34,9.22,1.97,100,1
Sajjadi et al.,2019,Breast,Breast Adenocarcinoma,MCF-7,Galbanic Acid,μM,48,hours,313.67,22.13,2.55,100,1
Sajjadi et al.,2019,Breast,Breast Adenocarcinoma,MCF-7,Galbanic Acid,μM,48,hours,156.84,43.76,2.04,100,1
Sajjadi et al.,2019,Breast,Breast Adenocarcinoma,MCF-7,Galbanic Acid,μM,48,hours,78.42,77.6,1.28,100,1
Sajjadi et al.,2019,Breast,Breast Adenocarcinoma,MDA-MB-231,Galbanic Acid,μM,48,hours,627.34,5.08,NA,100,1
Sajjadi et al.,2019,Breast,Breast Adenocarcinoma,MDA-MB-231,Galbanic Acid,μM,48,hours,313.67,17.81,2.03,100,1
Sajjadi et al.,2019,Breast,Breast Adenocarcinoma,MDA-MB-231,Galbanic Acid,μM,48,hours,156.84,34.86,NA,100,1
Sajjadi et al.,2019,Breast,Breast Adenocarcinoma,MDA-MB-231,Galbanic Acid,μM,48,hours,78.42,70.22,1.79,100,1
Valiahdi et al.,2013,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,96,hours,160,21,NA,100,1
Valiahdi et al.,2013,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,96,hours,82,76.71,NA,100,1
Valiahdi et al.,2013,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,96,hours,55,89.95,NA,100,1
Valiahdi et al.,2013,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,96,hours,28,91.32,NA,100,1
Valiahdi et al.,2013,Ovarian,Leukemia/Lymphoma,CH1,Galbanic Acid,μM,96,hours,82,31.4,NA,100,1
Valiahdi et al.,2013,Ovarian,Leukemia/Lymphoma,CH1,Galbanic Acid,μM,96,hours,55,69.08,NA,100,1
Valiahdi et al.,2013,Ovarian,Leukemia/Lymphoma,CH1,Galbanic Acid,μM,96,hours,28,80.19,NA,100,1
Valiahdi et al.,2013,Melanoma,Melanoma,SK-MEL-28,Galbanic Acid,μM,96,hours,160,17.15,NA,100,1
Valiahdi et al.,2013,Melanoma,Melanoma,SK-MEL-28,Galbanic Acid,μM,96,hours,82,61.27,NA,100,1
Valiahdi et al.,2013,Melanoma,Melanoma,SK-MEL-28,Galbanic Acid,μM,96,hours,55,90.68,NA,100,1
Zhang et al.,2012,Prostate,Prostate Carcinoma,DU145,Galbanic Acid,μM,72,hours,120,57.75,NA,100,1
Zhang et al.,2012,Prostate,Prostate Carcinoma,DU145,Galbanic Acid,μM,72,hours,80,84,NA,100,1
Zhang et al.,2012,Prostate,Prostate Carcinoma,DU145,Galbanic Acid,μM,72,hours,40,100,NA,100,1
Zhang et al.,2012,Prostate,Prostate Carcinoma,DU145,Galbanic Acid,μM,72,hours,20,100,NA,100,1
Zhang et al.,2012,Prostate,Prostate Carcinoma,DU145,Galbanic Acid,μM,72,hours,10,100,NA,100,1
Zhang et al.,2012,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,72,hours,120,7.8,NA,100,1
Zhang et al.,2012,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,72,hours,80,51,NA,100,1
Zhang et al.,2012,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,72,hours,62.73,72.75,NA,100,1
Zhang et al.,2012,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,72,hours,20,88.12,NA,100,1
Zhang et al.,2012,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,72,hours,10,91.5,NA,100,1
Zhang et al.,2012,Prostate,Prostate Carcinoma,LNCaP,Galbanic Acid,μM,72,hours,40,72.75,NA,100,1
Zhang et al.,2012,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,72,hours,120,75.34,NA,100,1
Zhang et al.,2012,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,72,hours,80,100,NA,100,1
Zhang et al.,2012,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,72,hours,40,100,NA,100,1
Zhang et al.,2012,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,72,hours,20,100,NA,100,1
Zhang et al.,2012,Prostate,Prostate Adenocarcinoma,PC-3,Galbanic Acid,μM,72,hours,10,100,NA,100,1
Zhang et al.,2019,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,48,hours,80,20.2,4.28,99.87,1
Zhang et al.,2019,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,48,hours,60,36.91,5.48,99.87,1
Zhang et al.,2019,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,48,hours,40,64.11,4.28,99.87,1
Zhang et al.,2019,Lung,Lung Adenocarcinoma,A549,Galbanic Acid,μM,48,hours,20,81.21,4.28,99.87,1
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,24,hours,54,99.2,1.74,99.9,1.36
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,24,hours,82,98.4,1.9,99.9,1.36
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,24,hours,110,97.8,2.13,99.9,1.36
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,24,hours,136,97,2.67,99.9,1.36
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,48,hours,54,100,3.42,100,5.38
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,48,hours,82,99.3,5.02,100,5.38
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,48,hours,110,92.9,2.8,100,5.38
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,48,hours,136,83.4,3.17,100,5.38
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,72,hours,54,95.7,2.38,93.8,2.34
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,72,hours,82,84.6,2.99,93.8,2.34
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,72,hours,110,60.1,9.38,93.8,2.34
Delbari et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,72,hours,136,54.5,5.07,93.8,2.34
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,24,hours,13.65,97,1.33,97.33,1.34
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,24,hours,27.3,96.67,2.66,97.33,1.34
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,24,hours,54.6,95,1.33,97.33,1.34
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,24,hours,109.2,92.67,1.33,97.33,1.34
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,48,hours,13.65,98.67,1.33,99,1
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,48,hours,27.3,98,1.67,99,1
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,48,hours,54.6,97.33,1,99,1
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,48,hours,109.2,97.33,1.34,99,1
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,72,hours,13.65,92,1,93.33,1.67
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,72,hours,27.3,91.67,1.66,93.33,1.67
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,72,hours,54.6,91,1,93.33,1.67
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,72,hours,109.2,91,1.67,93.33,1.67
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,96,hours,13.65,84.67,2.66,85.67,2
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,96,hours,27.3,84.67,1.33,85.67,2
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,96,hours,54.6,82.67,4.33,85.67,2
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,96,hours,109.2,82.33,2.34,85.67,2
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,120,hours,13.65,81.33,1,81.33,1.34
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,120,hours,27.3,80.33,4,81.33,1.34
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,120,hours,54.6,79.33,1.67,81.33,1.34
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,120,hours,109.2,78.67,1.33,81.33,1.34
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,144,hours,13.65,77.67,1.66,79.67,2
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,144,hours,27.3,76,6.33,79.67,2
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,144,hours,54.6,74,10.67,79.67,2
Ebrahimi et al.,2024,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,144,hours,109.2,71,1.67,79.67,2
Gkionis et al.,2021,Breast,Breast Adenocarcinoma,MDA-MB-231,Umbelliprenin,μM,48,hours,0.1,99.68,5.61,100,1
Gkionis et al.,2021,Breast,Breast Adenocarcinoma,MDA-MB-231,Umbelliprenin,μM,48,hours,1,89.71,14.65,100,1
Gkionis et al.,2021,Breast,Breast Adenocarcinoma,MDA-MB-231,Umbelliprenin,μM,48,hours,50,95.01,6.54,100,1
Gkionis et al.,2021,Breast,Breast Adenocarcinoma,MDA-MB-231,Umbelliprenin,μM,48,hours,100,40.8,3.74,100,1
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,48,hours,20,99.8,1,99.9,1
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,48,hours,40,99.9,1,99.9,1
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,48,hours,80,74.9,3.77,99.9,1
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,72,hours,20,99.2,1.51,99.39,1.51
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,72,hours,40,95.6,4.27,99.39,1.51
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,72,hours,80,60.3,12.61,99.39,1.51
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,96,hours,20,87.08,14.42,98.79,2.41
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,96,hours,40,75.67,24.63,98.79,2.41
Goudarzi et al.,2022,Leukemia/Lymphoma,Leukemia/Lymphoma,MT-2,Umbelliprenin,μM,96,hours,80,60.06,4.8,98.79,2.41
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,24,hours,6.25,95.66,1.45,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,24,hours,12.5,93.85,1.09,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,24,hours,25,85.51,1.08,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,24,hours,50,76.82,5.8,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,24,hours,100,56.89,2.17,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,24,hours,200,23.56,1.82,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,48,hours,6.25,95.29,2.53,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,48,hours,12.5,92.76,1.45,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,48,hours,25,81.53,2.54,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,48,hours,50,70.29,2.53,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,48,hours,100,33.34,1.09,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,48,hours,200,7.06,1.26,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,72,hours,6.25,81.53,2.54,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,72,hours,12.5,75.73,1.81,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,72,hours,25,69.93,2.17,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,72,hours,50,53.99,2.9,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,72,hours,100,36.96,2.9,100,1
Hamidinia et al.,2013,Colon,Colon Adenocarcinoma,SW48,Umbelliprenin,μM,72,hours,200,4.35,1.45,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,54.6,77.04,2.46,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,109.2,65.3,2.45,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,163.8,54.09,1.1,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,218.4,42.89,2.19,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,273,34.15,1.09,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,327.6,26.77,1.37,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,382.2,19.39,2.19,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,54.6,67.87,1.33,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,109.2,47.15,1.55,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,163.8,38.08,1,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,218.4,36.01,1.03,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,273,31.86,1.55,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,327.6,21.5,1.81,100,1
Kamalkazemi et al.,2023,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,382.2,14.24,1.56,100,1
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,24,hours,10,91,1.4,94.68,1.69
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,24,hours,20,80.27,1.97,94.68,1.69
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,24,hours,50,68.7,2.25,94.68,1.69
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,24,hours,100,51.49,8.16,94.68,1.69
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,24,hours,200,9.22,1.12,94.68,1.69
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,48,hours,10,86.31,1.97,97.31,1.97
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,48,hours,20,76.97,5.35,97.31,1.97
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,48,hours,50,64.56,4.22,97.31,1.97
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,48,hours,100,18.63,1.12,97.31,1.97
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,48,hours,200,9.13,1.4,97.31,1.97
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,72,hours,10,88.65,1.7,96.28,2.81
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,72,hours,20,79.33,4.5,96.28,2.81
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,72,hours,50,57.06,10.99,96.28,2.81
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,72,hours,100,19.56,1.4,96.28,2.81
Khaghanzadeh et al.,2012,Lung,Lung Adenocarcinoma,A549,Umbelliprenin,μM,72,hours,200,10.82,2.53,96.28,2.81
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,24,hours,10,94.82,2.01,93.1,1
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,24,hours,20,89.36,4.2,93.1,1
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,24,hours,50,81.69,3.44,93.1,1
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,24,hours,100,54.59,12.93,93.1,1
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,24,hours,200,32.18,6.32,93.1,1
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,48,hours,10,90.8,3.16,91.66,2.29
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,48,hours,20,87.06,2.58,91.66,2.29
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,48,hours,50,66.09,2.01,91.66,2.29
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,48,hours,100,31.6,10.91,91.66,2.29
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,48,hours,200,10.91,4.31,91.66,2.29
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,72,hours,10,86.2,5.17,91.95,2.58
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,72,hours,20,79.02,6.32,91.95,2.58
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,72,hours,50,72.12,5.45,91.95,2.58
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,72,hours,100,27.58,11.78,91.95,2.58
Khaghanzadeh et al.,2012,Lung,Lung Carcinoma,QU-DB,Umbelliprenin,μM,72,hours,200,5.74,2.29,91.95,2.58
Khatonabadi et al.,2024,Breast,Breast Carcinoma,T-47D,Umbelliprenin,μM,24,hours,50,96.52,15.51,100,1
Khatonabadi et al.,2024,Breast,Breast Carcinoma,T-47D,Umbelliprenin,μM,24,hours,100,81.82,7.75,100,1
Khatonabadi et al.,2024,Breast,Breast Carcinoma,T-47D,Umbelliprenin,μM,24,hours,150,63.64,15.5,100,1
Khatonabadi et al.,2024,Breast,Breast Carcinoma,T-47D,Umbelliprenin,μM,24,hours,200,62.57,4.27,100,1
Khatonabadi et al.,2024,Breast,Breast Carcinoma,T-47D,Umbelliprenin,μM,24,hours,250,54.81,4.82,100,1
Khatonabadi et al.,2024,Breast,Breast Carcinoma,T-47D,Umbelliprenin,μM,24,hours,300,48.4,12.3,100,1
Khatonabadi et al.,2024,Breast,Breast Carcinoma,T-47D,Umbelliprenin,μM,24,hours,600,32.89,9.36,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,24,hours,8.5,96.54,7.56,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,24,hours,17,98.28,2.58,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,24,hours,34,93.02,1.84,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,24,hours,68.2,71.52,5.37,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,24,hours,136.4,46.71,11.07,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,24,hours,272.8,23.55,3.5,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,24,hours,545.7,18.84,2.76,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,48,hours,17,96.99,6.08,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,48,hours,34,90.62,7.56,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,48,hours,68.2,71.15,5.9,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,48,hours,136.4,32.05,2.58,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,48,hours,272.8,10.44,2.02,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,48,hours,545.7,3.52,1.84,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,72,hours,8.5,98.19,10.7,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,72,hours,17,93.49,7.19,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,72,hours,34,89.7,11.07,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,72,hours,68.2,68.57,10.15,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,72,hours,136.4,41.91,3.32,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,72,hours,272.8,17.83,2.76,100,1
Rashidi et al.,2016,Glioma,Glioma,A172,Umbelliprenin,μM,72,hours,545.7,9.24,2.03,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,8.1,98.85,3.43,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,16.3,98.28,4,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,32.7,89.92,3.04,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,68.2,71.29,3.42,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,136.4,29.08,2.85,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,272.8,15.39,3.05,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,24,hours,545.7,6.27,1.71,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,8.1,99.23,3.05,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,16.3,89.92,3.61,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,32.7,92.38,3.62,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,68.2,64.06,4,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,136.4,25.28,2.85,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,272.8,18.63,2.85,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,48,hours,545.7,8.93,1.9,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,72,hours,8.1,99.04,3.24,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,72,hours,16.3,95.62,2.09,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,72,hours,32.7,92.01,2.66,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,72,hours,68.2,76.8,8.75,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,72,hours,136.4,28.13,3.99,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,72,hours,272.8,10.83,2.66,100,1
Rashidi et al.,2016,Colon,Colon Adenocarcinoma,HT-29,Umbelliprenin,μM,72,hours,545.7,3.99,2.28,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,24,hours,8.1,100,6.89,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,24,hours,16.3,97.82,4.72,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,24,hours,32.7,98.91,4.17,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,24,hours,68.2,59.52,6.17,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,24,hours,136.4,41.74,1.99,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,24,hours,272.8,20.14,1.81,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,24,hours,545.7,11.61,1.81,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,48,hours,8.1,98.91,7.98,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,48,hours,16.3,98,7.98,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,48,hours,32.7,93.1,2.35,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,48,hours,68.2,64.79,1.81,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,48,hours,136.4,30.82,1.6,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,48,hours,272.8,16.87,1.99,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,48,hours,545.7,8.34,1.81,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,72,hours,8.1,98.18,8.89,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,72,hours,16.3,96.37,9.8,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,72,hours,32.7,94.55,9.8,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,72,hours,68.2,89.83,6.89,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,72,hours,136.4,53.72,4.17,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,72,hours,272.8,17.96,2.9,100,1
Rashidi et al.,2016,Breast,Breast Adenocarcinoma,MCF-7,Umbelliprenin,μM,72,hours,545.7,9.8,2.17,100,1
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,BxPC3,Umbelliprenin,μM,24,hours,27.3,86.53,7.74,99.35,4.9
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,BxPC3,Umbelliprenin,μM,24,hours,54.6,80.8,5.39,99.35,4.9
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,BxPC3,Umbelliprenin,μM,24,hours,109.14,65.65,9.43,99.35,4.9
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,BxPC3,Umbelliprenin,μM,24,hours,218.3,53.53,7.41,99.35,4.9
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,BxPC3,Umbelliprenin,μM,24,hours,436.6,33.33,15.49,99.35,4.9
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,BxPC3,Umbelliprenin,μM,48,hours,27.3,81.81,1,100,8.26
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,BxPC3,Umbelliprenin,μM,48,hours,54.6,62.96,12.12,100,8.26
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,BxPC3,Umbelliprenin,μM,48,hours,109.14,45.79,12.79,100,8.26
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,BxPC3,Umbelliprenin,μM,48,hours,218.3,25.92,5.72,100,8.26
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,BxPC3,Umbelliprenin,μM,48,hours,436.6,17.5,11.79,100,8.26
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,Capan-1,Umbelliprenin,μM,24,hours,27.3,93.1,1,100,1
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,Capan-1,Umbelliprenin,μM,24,hours,54.6,83.1,4.83,100,1
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,Capan-1,Umbelliprenin,μM,24,hours,109.14,62.41,3.79,100,1
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,Capan-1,Umbelliprenin,μM,24,hours,218.3,43.79,4.48,100,1
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,Capan-1,Umbelliprenin,μM,24,hours,436.6,33.44,5.52,100,1
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,Capan-1,Umbelliprenin,μM,48,hours,27.3,85.51,1,100,1
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,Capan-1,Umbelliprenin,μM,48,hours,54.6,65.86,4.82,100,1
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,Capan-1,Umbelliprenin,μM,48,hours,109.14,50.34,7.93,100,1
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,Capan-1,Umbelliprenin,μM,48,hours,218.3,31.72,4.14,100,1
Wang et al.,2023,Pancreatic,Pancreatic Adenocarcinoma,Capan-1,Umbelliprenin,μM,48,hours,436.6,11.72,4.83,100,1
Wang et al.,2023,Pancreatic,Pancreatic Carcinoma,PANC-1,Umbelliprenin,μM,24,hours,27.3,85.66,3.07,100,1
Wang et al.,2023,Pancreatic,Pancreatic Carcinoma,PANC-1,Umbelliprenin,μM,24,hours,54.6,76.45,3.07,100,1
Wang et al.,2023,Pancreatic,Pancreatic Carcinoma,PANC-1,Umbelliprenin,μM,24,hours,109.14,60.75,4.09,100,1
Wang et al.,2023,Pancreatic,Pancreatic Carcinoma,PANC-1,Umbelliprenin,μM,24,hours,218.3,51.53,7.17,100,1
Wang et al.,2023,Pancreatic,Pancreatic Carcinoma,PANC-1,Umbelliprenin,μM,24,hours,436.6,33.78,5.12,100,1
Wang et al.,2023,Pancreatic,Pancreatic Carcinoma,PANC-1,Umbelliprenin,μM,48,hours,27.3,77.8,5.1,100,1
Wang et al.,2023,Pancreatic,Pancreatic Carcinoma,PANC-1,Umbelliprenin,μM,48,hours,54.6,60,6.86,100,1
Wang et al.,2023,Pancreatic,Pancreatic Carcinoma,PANC-1,Umbelliprenin,μM,48,hours,109.14,47.44,5.46,100,1
Wang et al.,2023,Pancreatic,Pancreatic Carcinoma,PANC-1,Umbelliprenin,μM,48,hours,218.3,33.1,9.9,100,1
Wang et al.,2023,Pancreatic,Pancreatic Carcinoma,PANC-1,Umbelliprenin,μM,48,hours,436.6,23.89,5.8,100,1
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,24,hours,6.25,87.72,1.43,97.72,1.72
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,24,hours,12.5,80.86,2.28,97.72,1.72
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,24,hours,25,71.43,2.57,97.72,1.72
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,24,hours,50,48,7.14,97.72,1.72
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,24,hours,100,20,2,97.72,1.72
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,24,hours,3.13,83.33,5.72,99.5,2.49
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,48,hours,3.13,72.13,1.5,100,1
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,72,hours,3.13,66.16,3.98,99.25,2.24
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,24,hours,6.25,63.68,2.73,99.5,2.49
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,48,hours,6.25,54.71,2.5,100,1
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,72,hours,6.25,52.83,4.04,99.25,2.24
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,24,hours,12.5,34.82,3.73,99.5,2.49
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,48,hours,12.5,32.58,2.74,100,1
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,72,hours,12.5,30.09,5.48,99.25,2.24
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,24,hours,25,24.37,1.99,99.5,2.49
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,48,hours,25,22.13,6.97,100,1
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,72,hours,25,20.14,2.99,99.25,2.24
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,24,hours,50,14.67,2.49,99.5,2.49
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,48,hours,50,12.68,2.24,100,1
Zhang et al.,2019,Gastric,Gastric Adenocarcinoma,AGS,Umbelliprenin,μM,72,hours,50,10.19,3.98,99.25,2.24
Ziai et al.,2012,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Umbelliprenin,μM,16,hours,10,92.47,1.94,100,1
Ziai et al.,2012,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Umbelliprenin,μM,16,hours,25,86.15,3.65,100,1
Ziai et al.,2012,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Umbelliprenin,μM,16,hours,50,63.06,2.92,100,1
Ziai et al.,2012,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Umbelliprenin,μM,16,hours,100,39.73,2.43,100,1
Ziai et al.,2012,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Umbelliprenin,μM,48,hours,10,69.18,2.74,100,1
Ziai et al.,2012,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Umbelliprenin,μM,48,hours,25,50.35,3.43,100,1
Ziai et al.,2012,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Umbelliprenin,μM,48,hours,50,25.69,3.08,100,1
Ziai et al.,2012,Leukemia/Lymphoma,Leukemia/Lymphoma,Jurkat T,Umbelliprenin,μM,48,hours,100,13.7,3.42,100,1